Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Alexion Pharmaceuticals and Complement Pharma announced a partnership to co-develop the preclinical C6 complement inhibitor CP010 for neurodegenerative disorders.
read more
Boehringer Ingelheim and the University of Dundee have extended their collaboration to develop new medicines that target and destroy key cancer causing proteins.
read more
Panthera and Rutherford Health have entered a collaboration to create a network of clinical trial sites for the development of new cancer treatments.
read more
Cambrex announced it will start a $5 million expansion of laboratory facilities at its Karlskoga, Sweden site.
read more
Lonza announced the addition of clinical bottling and labeling capabilities at its Small Molecules site in Bend, Oregon (US). Building upon the recent investment in the dedicated early-phase clinical manufacturing facility, the offering now includes ...
read more
Thursday, October 31, 2024
Sterling Pharma Solutions announced the second phase of an expansion strategy at its Deeside, UK site to support antibody-drug conjugate (ADC) development, with a more than £10 million investment to increase GMP bioconjugation capacity.
read more
Tuesday, December 02, 2025
Piramal Pharma Solutions announced the successful completion of its journey to compliance with global requirements for nitrosamine impurities in pharmaceuticals.
read more
Wednesday, November 19, 2014
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it has acquired Micron Technologies, a leading global ...
read more
Rich Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, has retained the services of an Asian contract research organization CMIC Asia-Pacific, Pte. Ltd., to run Rich's upcoming ...
read more
Icagen, Inc. announced today that the acquisition of Sanofi's ultra high-throughput biology, screening and chemistry capabilities and research facility in Oro Valley, Arizona (located nearTucson, Arizona) is officially complete.
read more
Wednesday, January 07, 2026
PSI CRO, a Swiss-based contract research organization, has expanded its Toronto operations with the opening of a new office location in Ontario. The expansion builds on PSI’s long-standing presence in the Canadian clinical trial market, where the ...
read more
Monday, February 14, 2022
Curia, formerly AMRI, announced that Integrity Bio and LakePharma, two companies that it acquired last year, have fully transitioned to the Curia brand. This change reflects the accelerated organizational integration of the acquired companies into ...
read more
Wednesday, October 31, 2018
Rho announced its membership in The Avoca Quality Consortium (AQC), a collaborative focused on quality and compliance in the execution of clinical trials.
read more
Clinical Ink announced the EMA has signaled its support of eSource DDC in a recent qualification opinion that specifically mentions Clinical Ink’s technology.
read more
Thursday, November 21, 2013
Pharmaceutical Product Development, LLC (PPD) today announced it has appointed Andrew Cunningham, Ph.D., as vice president of central laboratory services. Dr. Cunningham brings extensive biopharmaceutical industry experience to PPD’s central ...
read more